Home›Search›Expert Review of Pharmacoeconomics and Outcomes Research

Expert Review of Pharmacoeconomics and Outcomes Research

Taylor and Francis Ltd. · United Kingdom · Est. 1976

ISSN1473-7167eISSN1744-8379

SJR Q2✓ WOS SCIE✓ WOS SSCI✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.585

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.662

Total Works

2,294

Total Citations

37,377

2yr Mean Citedness

1.56

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the economic evaluation of healthcare interventions and treatments. It examines cost-effectiveness, cost-utility, and budget impact analyses across various diseases and patient populations. The scope includes assessing the value of new therapies, understanding the economic burden of illnesses, and informing healthcare policy and resource allocation decisions.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1976

Annual Volume~ 127 articles / year

StatusActive (last: 2026)

Total Publications2,294

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1473-7167 / 1744-8379

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ2

Medicine (miscellaneous)Q2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Health Care Sciences & ServicesHealth Policy & ServicesPharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Medicine (miscellaneous)Health Policy

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic and Financial Impacts of CancerHealthcare Policy and ManagementGlobal Health Care IssuesMedication Adherence and ComplianceHealthcare cost, quality, practicesEconomic and Environmental ValuationBiosimilars and Bioanalytical MethodsCancer survivorship and care